ACCURA PRESENTATION

And

AccuraMedizintechnik GmbHMaz-Planck-Strabe 33

61184 Karben, Germany.

INTERODUCING FIRST TIME IN PAKISTAN.

THE WORLD’S

FIRST DRUG ELUTINGACCURA STENT

ABN INTERNATIONAL AND ACCURA

AT ACCURA MEDICAL,DISESASE IS OUR TRUE CONPITITION

ACCURA DES Stent is our least weapon against a growing epidemic

Paclitaxel-Coated-Eluting Stent System

1. Coated with DLC (Diamond Like Carbon) for long term biocompatibility and covered with Polymer & Paclitaxel for slow release within 30 days.

2. High mechanical stability of the coating3. Star-shaped segments with flexible links to follow

vessel movements

Technical Specifications:Stent: Stainless steelDrug: Paclitaxel 1μg/mm²Coating Thickness: 1-2μmRelease kinetic:Slow release within 10-28 daysStent Surface finishing:DLC Pll (plasma ion implantation)Polymer:Inert polymer compound/ fully restorable.

A C C U R AMedizintechnik GmbH

Available Sizes,

27 Million

People Suffer from Peripheral Arterial Disease.

Also Known as PAD.

Smoking increases the risk of PAD by

2 to 4X

It is estimated that

20 %

Of people with PAD will suffer a non-fatal heart attack or stroke.

And nearly

30 %

Will die within

5 Year

A potential consequence of PAD is.

Amputation

With an annual aftercare Cost per patient of

$ 49,000

Rs. 3900000

And an average life expectancy after lower-limb amputation of

5 Years

The annual cost of aftercare for a PAD patient whose amputation has been prevented.

$ 800

Rs.160000

Thanks

Causes of PAD

Diabetes.

increasing14 % Annually

High Blood

Pressure

Causes of PAD

Causes Of PAD.H

igh

Cholester

ol

Causes of PAD

And Weighing

30 % More then

your ideal weight.

25%

Of the world’s

population

Which

includes:

#1Way to improve health.

Exercise.

Exercise.

2 of the leading reasons people avoid exercise and physical activity.

1)Lack of energy.

2)Leg pain and discomfort.

2 early symptoms of PAD

And so the cycle continues,

Introducing

A C C U R AMedizintechnik GmbHDrug-Eluting Stent

www.accuramed.de